secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001104659-25-044809
Event type: debt
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth enters $32.5M credit agreement with Callodine; warrants issued
--------------------------------------------------------------------------

- Borrowed $32.5M at closing; may draw up to $17.5M more subject to revenue thresholds and lender discretion.
- Loan bears interest at Term SOFR + 7.75%, matures April 2030; secured by substantially all assets.
- Issued warrants to purchase 2,114,140 shares at $0.8278; up to $2.5M loan principal convertible at $0.9933 per share.
- Prior Loan and Security Agreement with Avenue terminated; proceeds used to satisfy LSA.
- Financial covenants include minimum unencumbered liquid assets, total revenue, and Adjusted EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465925044809/0001104659-25-044809-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465925044809/tm2514078d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-044809

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer